BCA Weekly Commentary 12/24/21: Omicron Variant Panic or Opportunity


ECONOMIC IMPACT. Variability on economic growth assumptions for next year continue to hinge on Federal Reserve policy direction which has been fairly well defined. Speculation continues on Omicron and its impact on growth. In short term it may thwart growth, however, in time, it may prove to reduce risk to economic growth in 2022. From our own personal experience and research there exists much over hype concern on the severity of the new variant. However, despite elevated cases in short term symptom's remain MILD. The ramifications of which will serve to accelerate natural immunity which in term in 2022 may then REDUCE the threat to Covid-19 and thus overall cases. In countries such as Brazil & India vs USA & EU cases have been falling tied to lower vaccinations and broader use of therapeutics to treat Covid-19 leading to broader natural immunity. Despite the reliance & mandates of vaccinations especially in USA, the Omicron variant's rise in infects may then serve to accelera